Medicinesassessment Limited - Accounts to registrar (filleted) - small 18.1

REGISTERED NUMBER: 07367226 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2018

for

Medicinesassessment Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

Chartered Certified Accountants' Report

5

DIRECTOR:

Dr J Warren

REGISTERED OFFICE:

2 High Street

Burnham on Crouch

Essex

CM0 8AA

REGISTERED NUMBER:

07367226 (England and Wales)

ACCOUNTANTS:

Harvey Smith & Co Limited

Chartered Certified Accountants

2 High Street

Burnham on Crouch

Essex

CM0 8AA

FIXED ASSETS

Tangible assets

4

1

1

CURRENT ASSETS

Debtors

5

8,400

8,956

Cash at bank

27,059

31,592

35,459

40,548

CREDITORS

Amounts falling due within one year

6

10,673

10,722

NET CURRENT ASSETS

24,786

29,826

TOTAL ASSETS LESS CURRENT LIABILITIES

24,787

29,827

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

24,687

29,727

SHAREHOLDERS' FUNDS

24,787

29,827

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 19 April 2018 and were signed by:

Dr J Warren - Director

1.	STATUTORY INFORMATION

Medicinesassessment Limited is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared on a going concern basis. This assumes that the company will

continue in existence for the foreseeable future.

The validity of this assumption depends on the continued financial support of the directors and creditors.

If the company were unable to continue in operational existence, adjustments would have to be made to reduce

the balance sheet values of assets to their recoverable amounts, and to provide for any further liabilities that

might arise and to reclassify fixed assets as current assets. Long term liabilities would also have to be

reclassified as current liabilities.

The directors believe that it is appropriate for the financial statements to be prepared on the going concern basis.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,

value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that

have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the

timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2017 - 1 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2017

and 31 March 2018

2,767

DEPRECIATION

At 1 April 2017

and 31 March 2018

2,766

NET BOOK VALUE

At 31 March 2018

1

At 31 March 2017

1

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.18

31.3.17

£

£

Trade debtors

8,400

8,956

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.18

31.3.17

£

£

Trade creditors

639

-

Taxation and social security

9,555

10,243

Other creditors

479

479

10,673

10,722

7.	RELATED PARTY DISCLOSURES

During the year, total dividends of £45,000 (2017 - £35,000) were paid to the director .

8.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr J Warren.

The following reproduces the text of the report prepared for the director in respect of the company's annual

unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file

a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the

Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements of Medicinesassessment Limited for the year ended 31 March 2018 which comprise the Income

Statement, Balance Sheet and the related notes from the company's accounting records and from information and

explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the director of Medicinesassessment Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Medicinesassessment Limited and state those matters that we have agreed to state to the director of Medicinesassessment Limited in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Medicinesassessment Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Medicinesassessment Limited. You consider that Medicinesassessment Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Medicinesassessment Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Harvey Smith & Co Limited

Chartered Certified Accountants

2 High Street

Burnham on Crouch

Essex

CM0 8AA

19 April 2018